Laboratory methods of equine pregnancy diagnosis.

This study explains why many veterinarians wanted a dependable lab test for mare pregnancy and describes a simple, objective mouse-based bioassay that measures placental gonadotrophin in blood to meet that need.

It shows that quantifying the utero-ovarian response of immature female mice to a mare’s serum provides an accurate, sensitive, low-subjectivity laboratory diagnosis during the phase when placental gonadotrophin is high.

What problem were the authors addressing?

• Practitioners needed an independent, laboratory-based confirmation of pregnancy in mares, beyond on-farm rectal examination and rapid test kits.
• The demand was greatest during the gestational period when placental gonadotrophin (often termed pregnant mare serum gonadotrophin, PMSG; now commonly called equine chorionic gonadotrophin, eCG) is concentrated in maternal blood.
• An initial lab approach using agar gel diffusion was disappointing (insufficient sensitivity and interpretive subjectivity), prompting a search for a better method.

Background: existing methods and their limitations

• Rectal examination:
  • Reliable in skilled hands and offers immediate, in-clinic diagnosis.
  • Not an “independent” lab confirmation, and skill-dependent.
• On-farm PMSG/eCG kits:
  • Provide quick results but may vary in sensitivity/specificity and can require user interpretation.
  • Some practitioners still prefer centralized laboratory quality control and reporting.
• Agar gel diffusion (immunodiffusion) attempted as a lab service:
  • Found wanting for this application—insufficient analytical sensitivity during real-world sample variability and subjective reading of precipitin lines.
  • Produced too many inconclusive or borderline calls for a dependable service.

Design criteria for an “ideal” laboratory test

• Accuracy: correctly classifies pregnant versus non-pregnant mares.
• Sensitivity: detects the hormone at clinically relevant concentrations.
• Applicability to the “optimum request period”: performs best during the mid-gestation window when placental gonadotrophin peaks.
• Objective readout: minimizes user-dependent interpretation.
• Low inconclusive rate: clear positive/negative decisions for most submissions.
• Additional practicalities: acceptable cost, straightforward procedure, and reasonable turnaround time.

Rationale for reversing the trend back to a biological assay

• Although the field was moving from biological to immunological methods, the authors judged that available immunologic approaches (e.g., simple diffusion) did not meet the combined needs of sensitivity, objectivity, and low ambiguity for routine service.
• Classical biological assays for gonadotrophins are inherently sensitive because they measure an in vivo physiological response to the hormone, not just antibody binding.
• By quantifying that response, a biological test can yield an objective numerical result, mitigating the usual criticism of “subjectivity” in bioassays.

The chosen approach: a quantified mouse bioassay for PMSG/eCG

• Historical basis: Cole and Hart (1930) first identified PMSG using biological responses in small animals.
• Modification by the authors: use immature female mice and read out the utero-ovarian response elicited by eCG in a mare’s serum sample.
• Core principle: eCG has strong gonadotrophic activity in many species, stimulating ovarian and uterine changes that can be measured.
• Innovation: instead of a purely qualitative “present/absent” response, the authors quantified the response to generate a numerical index aligned with eCG concentration.

Method overview (as described in the abstract)

• Specimen: practitioner-submitted blood/serum from mares during the phase when placental gonadotrophin is abundant.
• Bioassay organism: immature female mice, chosen for robust ovarian/uterine responsiveness to gonadotrophins.
• Procedure concept:
  • Expose mice to aliquots of mare serum.
  • After a fixed interval, assess utero-ovarian endpoints (e.g., ovarian enlargement, follicular response, uterine changes).
  • Convert the observed response into a simple numerical score calibrated against controls/standards.
• Result interpretation: numerical thresholds map to “pregnant,” “non-pregnant,” or rarely “inconclusive.”
• Quality aims: minimize operator subjectivity, standardize handling, and provide reproducible outputs suitable for routine lab reporting.

Performance and accuracy (as claimed)

• The quantified bioassay met the primary requirements set by the authors:
  • Accuracy and sensitivity adequate for laboratory diagnosis during the optimal request period.
  • Objective, numerical readout substantially reduces subjective interpretation.
  • Low inconclusive rate compared with the agar gel diffusion approach.
• The paper also summarizes other available tests and their reported accuracies, positioning the modified mouse bioassay as a competitive or superior option for a lab service at the time.

Clinical and operational implications

• Service model: veterinarians can submit serum to a centralized lab and receive an objective, numerically supported pregnancy call.
• Best-use window: the assay is most informative during mid-gestation when eCG is highest; outside this window, sensitivity naturally declines as hormone levels wane.
• Complementarity: provides independent confirmation to augment rectal examination or on-farm kits, especially when operator skill or field conditions limit those methods.
• Turnaround/cost: designed to be practical for routine service, balancing animal use, lab throughput, and expense (details not quantified in the abstract).

Limitations and caveats

• Gestational timing:
  • High performance depends on sampling during the eCG-rich phase; very early or late gestation may yield false negatives.
• Physiological exceptions:
  • In mares, eCG can persist for a period even after embryonic loss once endometrial cups are established, potentially yielding a “pregnant” signal despite a nonviable or lost conceptus.
• Animal use:
  • Relies on a live-animal bioassay, which has ethical, regulatory, and logistical implications for modern laboratories.
• Generalizability:
  • Findings and performance claims are tied to the specific protocol and quality controls described by the authors; different implementations may vary.

Why the quantified bioassay matters

• Transforms a classic biological response into an objective, numerical laboratory test tailored to the mare’s hormonal physiology.
• Addresses practitioners’ need for a dependable, third-party pregnancy diagnosis during the optimal hormonal window.
• Demonstrates that, when thoughtfully designed and standardized, biological assays can rival or exceed certain immunologic tests for specific clinical tasks.

Key takeaways

• Rectal examination and rapid kits are useful, but many clinicians sought an independent lab test for confirmation.
• Agar gel diffusion lacked sensitivity and objectivity for routine service.
• A modified, quantified mouse bioassay for PMSG/eCG provided accurate, sensitive, and objective results with few inconclusives during the hormone-rich mid-gestation period.
• The approach met the predefined requirements for an ideal laboratory technique while remaining practical for service use.